ICE Bioscience is excited to announce our participation in the upcoming Discovery on Target 2024 conference, one of the premier events for drug discovery and development. The conference will be held from September 30 to October 3, 2024 in Boston, MA.

Dr. TJ Bing, SVP of Biology at ICE Bioscience, will deliver a podium presentation in Track C3A: Small Molecules for Cancer Targets. His talk, titled "Accelerating Hit Identification for Cancer Targets with the Biology Building Block Platform", will take place on Tuesday, October 1, 2024, at 2:35 PM.

In this 30-minute presentation, Dr. Bing will highlight ICE Bioscience's innovative Biology Building Block Platform, designed to streamline hit identification and accelerate drug discovery for cancer targets. This cutting-edge approach integrates biological insights and advanced screening technologies to enhance the efficiency of early-stage drug development, offering significant potential for cancer therapeutics.

We invite attendees to visit Booth #309 to meet our team and learn more about our latest advances in cancer drug discovery. Don't miss the opportunity to connect with us and explore how ICE Bioscience is shaping the future of oncology research.

We look forward to seeing you at Discovery on Target 2024!